<DOC>
	<DOCNO>NCT01737047</DOCNO>
	<brief_summary>The purpose study identify medical condition may cause particular problem individual receive care HIV infection age 50 . In addition , effect potentially side effect , HIV medication may change age , study also investigate association age differ effect antiretroviral therapy treatment outcomes , side effect level drug blood . Results study may inform future HIV treatment guideline monitor individual HIV infection . The result may also assist design future study treatment disease associate ageing .</brief_summary>
	<brief_title>A Prospective , Observational Study Examine Effects Ageing 'Pharmacokinetic Clinical Observations People Over Fifty '</brief_title>
	<detailed_description>Multicentre , prospective , observational study 3 year . Our study describe impact advance age experience live HIV England Ireland . To address establish cohort HIV-positive people age &gt; 50 &lt; 50 year well demographically match HIV-negative people age &gt; 50 year . 1 . To analyse incidence outcomes co-morbidities older-HIV-positive people relationship demographic/clinical factor . 2 . To evaluate association antiretroviral drug concentration age , assess potential impact age drug efficacy , drug-drug interaction co-morbidities . 3 . To contribute development implementation evidence-based recommendation clinical monitoring old HIV-positive patient . 2000 recruit either white black african individual ( self report ) 1000 Over 50 year age HIV positive , 500 age 50 HIV positive 500 age 50 HIV negative .</detailed_description>
	<mesh_term>HIV Seropositivity</mesh_term>
	<mesh_term>Integrase Inhibitors</mesh_term>
	<criteria>Older HIVpositive cohort ( n=1000 ) : document HIV infection age &gt; 50 year study entry self define white black African ethnicity likely route HIV acquisition via sexual exposure Either male male exposure white heterosexual exposure white black African able comprehend study patient information leaflet Younger HIVpositive cohort ( n=500 ) : document HIV infection age &lt; 50 study entry* self define white black African ethnicity likely route HIV acquisition via sexual exposure Either male male exposure white heterosexual exposure white black African . able comprehend study patient information leaflet group comprise least 150 subject follow age group : 2029 , 3039 , 4049 year . Recruitment monitor Study Monitoring Team . HIVnegative cohort ( n=500 ) : document negative HIV test screening age &gt; 50 year study entry self define white black African ethnicity register General Practitioner give permission contact General Practitioner . opinion investigator , unable unwilling comply requirement study life expectancy le 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>HIV</keyword>
	<keyword>Ageing</keyword>
</DOC>